| Date Filed | Type | Description |
| 06/15/2023 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0.49, valued at
$4.9k
|
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $3.27, valued at
$408.8k
|
|
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $4.31, valued at
$21.6k
|
|
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $3, valued at
$15k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Green Ralph Elias (Director) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.72, valued at
$81.6k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Singh Gurdev Dave (Chief Medical Officer) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.72, valued at
$81.6k
|
|
| 08/10/2021 |
4
| Lindsay Mark F. (Director) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.72, valued at
$81.6k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2021 |
3/A
| Huntsman Ronald Kirk (Chairman and CEO) has filed a Form 3/A on Vivos Therapeutics, Inc. |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $5.38, valued at
$21.5k
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Amman Bradford K. (CFO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.38, valued at
$7.4k
|
|
| 12/23/2020 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.2669, valued at
$7.3k
|
|
| 12/14/2020 |
4
| Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $8.5, valued at
$4.3k
|
|
| 12/10/2020 |
3
| SOKOLOW LEONARD J (Director) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Thompson Matthew (Director) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Singh Gurdev Dave (Chief Medical Officer) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Green Ralph Elias (Director) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Amman Bradford K. (CFO) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Huntsman Ronald Kirk (Chairman & CEO) has filed a Form 3 on Vivos Therapeutics, Inc. |
| 12/10/2020 |
3
| Lindsay Mark F. (Director) has filed a Form 3 on Vivos Therapeutics, Inc. |